TCL Archive NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration October 29, 1999
TCL Archive As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel. October 20, 2000
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing October 10, 1980